New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s proprietary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A Virginia-based biotech company has announced dosing of ...

In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve ...

Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune ...

In a recent study published in Respiratory Medicine, researchers reported that silent hypoxia was not unique to coronavirus disease 2019 (COVID-19). Silent hypoxemia syndrome, well-tolerated hypoxemia ...

Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...